PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-10
DOI
10.3389/fncel.2018.00099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglia-glioma cross-talk a two way approach to new strategies against glioma
- (2017) Cataldo Arcuri Frontiers in Bioscience-Landmark
- The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration
- (2017) Birgit Ritschka et al. GENES & DEVELOPMENT
- Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer
- (2017) Changwen Ning et al. Oncotarget
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Evaluation of Akt and RICTOR Expression Levels in Astrocytomas of All Grades
- (2016) Arthur William Alvarenga et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
- (2015) Kazuhiro Tanaka et al. JOURNAL OF CLINICAL INVESTIGATION
- Significance of filamin A in mTORC2 function in glioblastoma
- (2015) Naphat Chantaravisoot et al. Molecular Cancer
- Current treatment strategies for inhibiting mTOR in cancer
- (2015) Francesca Chiarini et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex
- (2015) Sergiusz Jóźwiak et al. Seminars in Pediatric Neurology
- mTOR kinase inhibitor pp242 causes mitophagy terminated by apoptotic cell death in E1A-Ras transformed cells
- (2015) Serguei A. Gordeev et al. Oncotarget
- Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3
- (2014) Hiroshi Aoki et al. Autophagy
- Autophagy regulation and its role in cancer
- (2013) Séverine Lorin et al. SEMINARS IN CANCER BIOLOGY
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Autophagy and cancer
- (2012) Kyeong Sook Choi EXPERIMENTAL AND MOLECULAR MEDICINE
- Autophagy modulation as a potential therapeutic target for diverse diseases
- (2012) David C. Rubinsztein et al. NATURE REVIEWS DRUG DISCOVERY
- Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
- (2012) R. C. Wang et al. SCIENCE
- Autophagy in Brain Tumors: A New Target for Therapeutic Intervention
- (2011) Niroop Kaza et al. BRAIN PATHOLOGY
- The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer
- (2011) Jatin Roper et al. PLoS One
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Oncogenic EGFR Signaling Activates an mTORC2-NF- B Pathway That Promotes Chemotherapy Resistance
- (2011) K. Tanaka et al. Cancer Discovery
- Autophagy is a therapeutic target in anticancer drug resistance
- (2010) Suning Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- mTOR-Mediated Activation of p70 S6K Induces Differentiation of Pluripotent Human Embryonic Stem Cells
- (2010) Charles A. Easley et al. Cellular Reprogramming
- mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide
- (2010) Won Jun Oh et al. EMBO JOURNAL
- Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer
- (2010) T Sato et al. ONCOGENE
- Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
- (2010) Zhi Huang et al. Protein & Cell
- The prognostic role of Beclin 1 protein expression in high-grade gliomas
- (2009) Luigi Pirtoli et al. Autophagy
- Role and regulation of autophagy in cancer
- (2009) Ning Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- TORC-Specific Phosphorylation of Mammalian Target of Rapamycin (mTOR): Phospho-Ser2481 Is a Marker for Intact mTOR Signaling Complex 2
- (2009) J. Copp et al. CANCER RESEARCH
- mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging
- (2009) Rogerio M. Castilho et al. Cell Stem Cell
- mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling
- (2009) L.-A. Julien et al. MOLECULAR AND CELLULAR BIOLOGY
- Nutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for Autophagy
- (2009) Nao Hosokawa et al. MOLECULAR BIOLOGY OF THE CELL
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
- (2008) Valeria Facchinetti et al. EMBO JOURNAL
- Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
- (2008) A. Y. Choo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now